Wolverine Trading, LLC My Md Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.1 - $2.86 $1,531 - $3,981	1,392 Added 8.59%	17,601 $30,000
Q4 2022 Feb 14, 2023	SELL	$0.92 - $96.0 $11,727 - $1.22 Million	-12,747 Reduced 44.02%	16,209 $19,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $64,282 - $2.38 Million	28,956 New	28,956 $74,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $4.78 $25,232 - $60,304	-12,616 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.34 - $6.05 $18,844 - $34,134	-5,642 Reduced 30.9%	12,616 $56,000
Q4 2021 Feb 14, 2022	BUY	$5.46 - $9.69 $14,769 - $26,211	2,705 Added 17.39%	18,258 $100,000
Q3 2021 Nov 12, 2021	BUY	$4.64 - $7.94 $72,165 - $123,490	15,553 New	15,553 $112,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.